Ence Chuck 4
4 · RELMADA THERAPEUTICS, INC. · Filed Dec 16, 2025
Insider Transaction Report
Form 4
Ence Chuck
CAO and COO
Transactions
- Award
Stock Appreciation Rights
2025-12-12+828,000→ 828,000 totalExercise: $4.06From: 2026-03-12Exp: 2035-12-12→ Common Stock (828,000 underlying)
Footnotes (1)
- [F1]The stock appreciation rights vest in 16 equal quarterly installments commencing on March 12, 2026.